skip to Main Content

About PILA PHARMA

PILA PHARMA is a privately held clinical stage pharmaceutical company based in Malmö, Sweden.
PILA PHARMA is developing a novel type of oral anti-diabetic agent: a TRPV1 antagonist for the treatment of diabetes.

The company owns issued use-patents giving the right to treat diabetes and obesity with TRPV1 antagonists.
Our safe clinical development candidate, XEN-D0501, entered the first clinical trials in type-2 diabetic patients in 2017.

Announcement

HAR DU TYPE 2 DIABETES OG ØNSKER DU AT INDGÅ I ET LÆGEMIDDEL FORSØG?

We are extremely proud to inform you that, as of today, our Opinion and Concept Paper on the role of TRPV1 in diabetes is finally published in Trends in Molecular Medicine!

Read the paper here

(11-Nov-2017)

We’re very pleased to share PILA PHARMA AB‘s new Youtube channel.

The first film shows a guest lecture at Prague University in September 2017 where CEO Dorte X. Gram talked to students about starting up a biotech company.

Watch the video here

(04-Sep-2017)

Meet Us At

78th Scientific Sessions

Orlando, Florida
June 22 – 26, 2018

Interview

Pila Pharma

Veckans Affärer sponsored one of the prizes at the Almi Invest pitch competition that PILA PHARMA won in December 2016.

Check out the resulting article here

(13-Dec-2017)

Uppstickaren som vill ta plats i läkemedelsindustrin.
An interview with CEO Dorte X. Gram published in ‘DI Almedalen, Distributed with Dagens Industri, Sweden.

Read the article in Swedish here

(03-Jul-2017)

We are proud to be on the cover of the June 2017 issue of Affärslivet Norden, Medicine and Science magazine that focuses on innovation.
The magazine was distributed with Svenska Dagbladet.

Read the article in Swedish here
Read the magazine in Swedish here

(22-Jun-2017)

Stora förhoppningar på nytt effektivt läkemedel mot diabetes typ 2.
An interview with CEO Dorte X. Gram  published in ‘Analys Öresund’, Distributed with Dagens Industri, Sweden.

Read the article in Swedish here
Read the magazine in Swedish here

(15-Jun-2017)

“Min uppfinning kom och hämtade tillbaka mig”
Dr. Dorte X. Gram, CEO of PILA PHARMA was interviewed by Sydsvenskan, Sweden.

Read the article in Swedish here

(04-Dec-2016)

We are proud to be on the cover of the September 2016 issue of Nordic Life Science Magazine as representatives of Nordic Life Science companies.

Read the article here
Read the magazine here

(09-Sep-2016)

At BioEurope Spring in Stockholm in April 2016 Dr. Dorte X. Gram, CEO of PILA PHARMA was interviewed by the organizers about the current status and our plans going forward.

Please find the links below:
partnering360.com

(08-Apr-2016)

Investor presentation at ‘Next Big Thing’ (by Blasieholmen Investment Group)
Moderna Museet, Stockholm, Sweden

Watch the presentation here
Direct link to presentation here

(02-Dec-2016)
For more information please contact us
Back To Top
Close search
Search